According to the company, enVista Envy IOLs will be commercially available in the U.S. on a limited basis in the coming weeks ...
Bausch + Lomb Corporation , a leading global eye health company dedicated to helping people see better to live better, today announced that the U.S. Food and Drug Administration has approved the ...
enVista Envy IOLs will be commercially available in the U.S. on a limited basis in the coming weeks and more broadly in 2025. Bausch + Lomb is also in the process of seeking regulatory approvals for ...
Cataracts, a common eye condition that clouds vision and hampers daily activities, can now be treated with innovative ...